SEARCH RESULTS FOR: "Tag: ZTS"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(3)
2017(1)
2016(3)
2015(1)
CATEGORIES
Analyst Downgrades(1)
Buzz Stocks(1)
Early Edge(1)
Expectational Analysis(1)
Opening View(1)
Quantitative Analysis(3)
Technical Analysis(2)

12/7/2018 12:28 PM
The shares of animal drug maker Zoetis Inc (NYSE:ZTS) have taken a breather since touching a record high of $96.57 in early November. However, the outperforming equity could be ready to launch its n...
5/21/2018 1:37 PM
Animal drug maker Zoetis Inc (NYSE:ZTS) made headlines last week, after announcing plans to buy Abaxis (ABXS) for about $1.9 billion. ZTS shares have moved higher since the announcement, and are back...
4/11/2018 2:03 PM
Biotechs struggled in the latter half of March, with the iShares Nasdaq Biotechnology ETF (IBB) shedding more than 13% from its mid-March high of $115.60 to its early April lows just north of $100. Th...
3/7/2017 11:12 AM
Drug stocks are taking a hit this morning after last night's release of a plan to replace Obamacare by Republican members of Congress. Adding to the pressure was an early tweet this morning from Pre...
8/22/2016 9:51 AM
U.S. stocks are in the red this morning, after another Fed official took a relatively hawkish tone toward interest rates. Meanwhile, among specific equities in focus are biotechs Medivation Inc (NAS...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center